Nordea Investment Management’s AstraZeneca AZN Stock Holding History

Nordea Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,944	Closed	-$2.75M	–	869
2025 Q4	$2.75M	Buy	14,944 +10,317	+223%	+$1.81M	﹤0.01%	711
2025 Q3	$692K	Buy	4,627 +329	+8%	+$49.8K	﹤0.01%	831
2025 Q2	$600K	Hold	4,298	–	–	﹤0.01%	847
2025 Q1	$624K	Sell	4,298 -1,441	-25%	-$208K	﹤0.01%	849
2024 Q4	$754K	Buy	+5,739	New	+$803K	﹤0.01%	840
2022 Q4	–	Sell	-12,660	Closed	-$1.4M	–	951
2022 Q3	$1.4M	Sell	12,660 -24,724	-66%	-$3.14M	﹤0.01%	735
2022 Q2	$4.89M	Sell	37,384 -13,577	-27%	-$1.78M	0.01%	542
2022 Q1	$6.87M	Sell	50,961 -3,119	-6%	-$374K	0.01%	522
2021 Q4	$6.33M	Sell	54,080 -991	-2%	-$117K	0.01%	537
2021 Q3	$6.64M	Buy	+55,071	New	+$6.41M	0.01%	547

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Nordea Investment Management's AZN Position: Q1 2026 in Review

Nordea Investment Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 14,944 shares — an estimated $2.75M sold.

Nordea Investment Management first reported a position in AZN in Q3 2021 and held it in 10 quarters. The position peaked at $6.87M in Q1 2022. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Nordea Investment Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Nordea Investment Management sold 14,944 AstraZeneca shares in Q1 2026, an estimated $2.75M.
Nordea Investment Management first reported a position in AstraZeneca in Q3 2021 and held it in 10 quarters.
Nordea Investment Management's AstraZeneca position peaked at $6.87M in Q1 2022.
1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.